Related Experiment Videos
[VEPA therapy in B-lymphoma]
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 1, 1986
Abstract:
48 previously untreated adult patients with B-lymphoma were treated with VEPA therapy. The complete remission rate was 79.2%. 48% of the patients were still alive after 4 years of the therapy. About 90% of the patients of stage II was expected to be cured by the therapy. VEPA therapy is greatly effective to B-lymphoma.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Tirabrutinib hydrochloride for B-cell lymphomas.
Drugs of today (Barcelona, Spain : 1998)·2021
Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: final results from the PILLAR-2 randomized phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).
Annals of oncology : official journal of the European Society for Medical Oncology·2017
[Prostate-Preserving Curative Surgery for Isolated Peritoneal Recurrence with Seminal Vesicle Invasion Following Sigmoid Colon Cancer Resection-A Case Report].
Gan to kagaku ryoho. Cancer & chemotherapy·2026
[Association Between Tertiary Lymphoid Structures and Intratumoral Microbiota in Lung Cancer].
Gan to kagaku ryoho. Cancer & chemotherapy·2026
[A Case of Pembrolizumab-Associated Fulminant Type One Diabetes Mellitus during Neoadjuvant Chemotherapy for Early-Stage Breast Cancer].
Gan to kagaku ryoho. Cancer & chemotherapy·2026
[A Case of Giant Exophytic Gastric GIST Presenting with the Torricelli-Bernoulli Sign during Regorafenib Treatment].
Gan to kagaku ryoho. Cancer & chemotherapy·2026
[A Case of Post-Transplant Lymphoproliferative Disorder with Suspected Thrombosis Leading to Discontinuation of Daprodustat Following Pharmacist Intervention].
Gan to kagaku ryoho. Cancer & chemotherapy·2026
[A Case of Stage Ⅳ Lung Adenocarcinoma with Bilateral Breast Metastases Mimicking Inflammatory Breast Cancer].
Gan to kagaku ryoho. Cancer & chemotherapy·2026
Management of ectopic Cushing syndrome in medullary thyroid carcinoma: from case reports to systematic literature review.
Frontiers in endocrinology·2026
Catatonic Features That May Be Mistaken for Worsening Autism Show Treatment-Associated Improvement: Implications for Later Regression.
medRxiv : the preprint server for health sciences·2026
Integrative pipeline to profile and target endocrine therapy-insensitive cell populations in ER+ breast cancer.
bioRxiv : the preprint server for biology·2026